AnnJi Pharmaceutical Co., Ltd. (7754.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan · ISIN TW0007754004

Price
65.00 TWD
Market cap
6.16 bn TWD
P/E (2025)
–
P/S (2025)
815.94
Dividend yield
0.00 %
Net margin
-4,738.73 %
Return on equity (ROE)
-111.90 %
Return on assets (ROA)
-60.64 %

AnnJi Pharmaceutical Co., Ltd. financials

Fiscal year20242025
Revenue96.45 m TWD7.55 m TWD
Gross profit8.89 m TWD1.26 m TWD
Operating income-360.14 m TWD-369.37 m TWD
EBIT-360.14 m TWD-356.27 m TWD
Net income-353.99 m TWD-357.87 m TWD
Diluted EPS – continuing operations-3.81 TWD-3.78 TWD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About AnnJi Pharmaceutical Co., Ltd.

AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis. AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.